Roland Heinig

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Cardiovascular Events

Gold Nanoparticles

Top Venues

European journal of drug metabolism and pharmacokinetics

CPT: pharmacometrics & systems pharmacology

Diabetes, obesity & metabolism

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, Martijn van Noort, Martijn Ruppert, Martijn van Noort, Dirk Garmann, Joerg Lippert, Roland Heinig, Meike Brinker, Hiddo J Lambers Heerspink
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD. Diabetes, obesity & metabolism (2023)
Roland Heinig, Thomas Eissing
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone. Clinical pharmacokinetics (2023)
Roland Heinig, Robert Fricke, Sebastian Wertz, Johannes Nagelschmitz, Stephanie Loewen
Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3. European journal of drug metabolism and pharmacokinetics 47 (6) (2022)
Roland Heinig, Johannes Nagelschmitz, Stephanie Loewen
Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers. European journal of drug metabolism and pharmacokinetics 47 (4) (2022)
Thomas Wendl, Sebastian Frechen, Michael Gerisch, Roland Heinig, Thomas Eissing
Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone. CPT: pharmacometrics & systems pharmacology (2021)
Roland Heinig, Michael Gerisch, Michaela Bairlein, Johannes Nagelschmitz, Stephanie Loewen
Results from Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications. European journal of drug metabolism and pharmacokinetics 45 (4) (2021)
Roland Heinig, Marc Lambelet, Johannes Nagelschmitz, Abir Alatrach, Atef Halabi
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment. European journal of drug metabolism and pharmacokinetics 44 (5) (2020)
Roland Heinig, Michael Gerisch, Anna Engelen, Johannes Nagelschmitz, Stephanie Loewen
Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug-Drug Interaction Studies In Vitro and In Vivo. European journal of drug metabolism and pharmacokinetics 43 (6) (2019)